Secondary malignant neoplasm of breast
ICD-10 C79.81 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of breast.
C79.81 refers to a secondary malignant neoplasm of the breast, indicating that cancer has metastasized to the breast tissue from a primary site elsewhere in the body. This condition is often associated with advanced stages of cancer, where the primary tumor may be unknown or previously treated. The breast tissue becomes a site for secondary tumors, which can lead to various symptoms, including pain, swelling, and changes in breast appearance. The management of secondary malignant neoplasms often involves palliative care, focusing on symptom relief and quality of life rather than curative treatment. Staging of metastatic breast cancer is crucial for determining the extent of disease and guiding treatment options. The presence of secondary malignancies can complicate the clinical picture, necessitating a multidisciplinary approach to care, including oncologists, radiologists, and palliative care specialists.
Detailed history of primary cancer, staging information, and treatment history.
Patients with known primary cancers presenting with new breast lesions.
Ensure clarity in distinguishing between primary breast cancer and metastatic disease.
Comprehensive symptom management plans and goals of care discussions.
Patients with advanced cancer requiring symptom relief and quality of life considerations.
Documentation should reflect the focus on palliative measures and patient preferences.
Used for imaging in patients with suspected metastatic disease.
Indication for MRI and findings related to metastatic disease.
Oncologists should ensure imaging results are clearly linked to the diagnosis.
Primary malignant neoplasm of the breast originates in the breast tissue, while secondary malignant neoplasm indicates that cancer has spread to the breast from another primary site in the body. Accurate coding requires clear documentation of the primary cancer.
